"Through a new collaboration with a South Korean pharmaceutical company, UCLA scientists will participate in the process to develop a new drug to treat multiple sclerosis."
Dr. Bruce Dobkin has been recognized as Outstanding Reviewer for 2021 for the journal Stroke! Dr. Dobkin’s review work is noted for its quality, timeliness and volume.
UCLA Goldberg Migraine Program fellow Dr. Peony Pak and PGY-4 resident Dr. Shawn Love received scholarships for their research abstracts at the recent 2021 Headache Cooperative of the Pacific Annual Winter Conference. Congratulations to you both!
There have been clinical trials of migraine preventive treatments over the last six decades, leading to the approval of many medications & devices. Dr. Peter Goadsby contributed to this review focused on outcomes in preventive migraine clinical trials.
Is percutaneous patent foramen ovale (PFO) closure a safe way of treating migraine? Dr. Andrew Charles & others found that PFO closure significantly reduced the number of monthly migraine days and attacks.
Congratulations to Dr. Charles Flippen for his nomination to the American Academy of Neurology Executive Board as Treasurer of the AAN! He currently serves as Secretary-Treasurer of the AAN Institute.
Congratulations to Dr. Jeffrey Saver on a newly published book, Stroke Prevention and Treat: An Evidence-Based Approach, 2nd ed. The book was published by Cambridge University Press this past month. Dr. Saver co-edited the book with Dr. Graeme Hankey from Australia and wrote/co-wrote 9 of the 26 chapters.
Congratulations to Dr. Noah Zaitlen on a new R01 entitled "Rarely Common: Uncovering the dominant role of rare variants in the genetic architecture of complex human traits"!
What causes inferior rectus (IR) underaction in the eye? Dr. Joseph Demer sought to investigate the clinical and imaging characteristics of congenital and acquired causes of IR underaction.
